A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Clinical trial NCT01441388 · WITHDRAWN

Trial details

NCT number: NCT01441388
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Glioblastoma Carcinoma, Hepatocellular

Start date: 2011-12-01
Primary completion: 2013-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.